Bowel Function After Minimally Invasive Urogynecologic Surgery
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 4/21/2016 |
| Start Date: | November 2009 |
| End Date: | February 2011 |
Bowel Function After Minimally Invasive Urogynecologic Surgery: A Prospective Randomized Controlled Trial
The purpose of this study is to assess the effect of a standardized postoperative bowel
regimen of over-the-counter medications in subjects undergoing minimally invasive
urogynecologic surgery.
regimen of over-the-counter medications in subjects undergoing minimally invasive
urogynecologic surgery.
See above
Inclusion Criteria:
- Planning to be admitted to the hospital to undergo minimally-invasive urogynecologic
surgery at Strong Memorial Hospital.
Procedures may include:
- robot-assisted laparoscopic sacrocolpopexy
- sacrospinous ligament suspension
- uterosacral ligament suspension/paravaginal defect repair
- colpocleisis
- cystocele repair
Additional procedures may include:
- hysterectomy
- adnexectomy
- culdoplasty
- minimally invasive sling procedure (TVT or TOT)
- periurethral collagen injections
- enterocele repair
Exclusion Criteria:
- Planning to undergo laparotomy.
- Undergoing rectocele or perineocele repair as part of surgery.
- Taking Miralax, laxatives, enemas, or suppositories daily, at the time of enrollment.
- Presence of a colostomy.
- Chronic kidney disease
- Insulin-dependent diabetes mellitus
- Known cardiac disease
- Gastric ulcers
- Difficulty swallowing or esophageal stricture
- Persistent nausea and vomiting
- Signs and symptoms consistent with bowel obstruction
We found this trial at
1
site
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
